Conmed (CNMD) Amortization of Deferred Charges (2019 - 2026)

Conmed has reported Amortization of Deferred Charges for 8 years, with the latest figure at $1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Amortization of Deferred Charges fell 11.57% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $5.5 million (down 4.48% YoY), and the FY2025 full-year result was $5.6 million, down 0.95% from the prior year.
• Amortization of Deferred Charges for Q1 2026 stood at $1.3 million, up from -$36.7 million in the prior quarter.
• The five-year high for Amortization of Deferred Charges was $50.1 million in Q4 2022, with the low at -$36.7 million in Q4 2025.
• Historically, Amortization of Deferred Charges has averaged $4.2 million across 5 years, with a median of $1.4 million in 2025.
• The largest YoY upside for Amortization of Deferred Charges was 837.3% in 2023 against a maximum downside of 171.25% in 2023.
• Conmed's Amortization of Deferred Charges stood at $50.1 million in 2022, then plunged by 171.25% to -$35.7 million in 2023, then declined by 0.22% to -$35.7 million in 2024, then decreased by 2.69% to -$36.7 million in 2025, then surged by 103.48% to $1.3 million in 2026.
• The last three Amortization of Deferred Charges figures came in at $1.3 million (Q1 2026), -$36.7 million (Q4 2025), and $39.5 million (Q3 2025), per Business Quant data.